Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Climb Bio, Inc. (CLYM) had Normalized Income after Taxes of $-8.67M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-8.67M |
|
-- |
|
-- |
|
$10.68M |
|
$-10.68M |
|
$2.01M |
|
$-8.67M |
|
$-8.67M |
|
$-8.67M |
|
$-8.67M |
|
$-8.67M |
|
|
Normalized Income after Taxes |
$-8.67M |
$-10.68M |
|
$-11.21M |
|
67.59M |
|
67.59M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$87.38M |
|
$0.31M |
|
$105.00M |
|
$192.39M |
|
$6.21M |
|
-- |
|
$0.42M |
|
$6.62M |
|
$185.76M |
|
$185.76M |
|
$185.76M |
|
67.26M |
|
| Cash Flow Statement Financials | |
$-26.58M |
|
$-37.97M |
|
-- |
|
$87.23M |
|
$22.68M |
|
$-64.55M |
|
$3.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.08 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.67% |
|
-4.67% |
|
-4.50% |
|
-4.67% |
|
$2.76 |
|
$-0.39 |
|
$-0.39 |
|